Takeaway

• Clopidogrel monotherapy beyond the initial 6-18 months of dual antiplatelet therapy (DAPT) was superior to aspirin monotherapy in patients who have had percutaneous coronary intervention (PCI) with a drug-eluting stent (DES).

Why this matters

• There is limited evidence regarding optimal antiplatelet monotherapy during the long-term maintenance period in patients...